• Staff
10 March 2026

Iconeus announces creation of U.S. subsidiary

Press Release

Share this

As fUS becomes more widely adopted in the U.S. (as well as elsewhere around the world), we’ve appointed Joshua Dufresne as Business Development Manager, working within our new U.S. subsidiary, Iconeus Inc.

We hope that this new presence will help us collaborate more closely with academics, research institutes, pharmaceutical companies and CROs in the U.S., and so support the adoption of fUS for a broader range of applications.

For full details, read the news release below:


Press contact: 

Djamel Zekri, Djamel.zekri@iconeus.com

Iconeus
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.